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Summary
A case of a severe overdose of sodium valproate
(more than 10 times the therapeutic requirement) is
discussed. The patient presented with central ner-
vous. respiratory and cardiovascular depression and
was treated with supportive therapy and haemoper-
fusion. However. on available data it would appear
that haemoperfusion did not make a significant contri-
bution towards the patient's recovery.
the left lung; this revealed only mucopurulent material in the
bronchi.
The blood level of SV was 1080 /-lg/ml on admission and
haemoperfusion was performed for 8 hours (activated charcoal,
150-200 ml/min). The change in blood levels of SV are shown
in Fig. I. The patient regained consciousness shortly after he
had been haemoperfused for the second time for 5 hours 18
hours after admission and he was weaned from the ventilator
35 hours after admission. Follow-up liver and kidney function
tests and haematological investigations revealed no abnor-
malities.
S Air Med J 1985; 17: 735-736.
Discussion
Fig. 1. The decrease in blood SV concentration in relation to time
in hours.
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Self-poisoning is an important complication of epilepsy' and
the only commonly prescribed anticonvulsant for which the
effects of an overdose are well known is phenobarbitone. 2
Specifically, there is insufficient reliable data on the effect of
SV in above-normal dosages and from cases reviewed by the
Poisons Unit, Guy's Hospital, London,3 it is reasonable to
conclude that plasma concentrations 5 - 6 times the maximum
therapeutic concentration (therapeutic blood concentration 50-
100 /-lg/ml) are unlikely to be accompanied by symptoms other
than nausea, vomiting and dizziness. With a massive overdosage
where plasma concentrations reach 10 - 20 times the normal
therapeutic requirements, central nervous system and respira-
tory depression can be expected to occur - as in this case.
There is no general consensus about the treatment of SV
overdose and forced diuresis, haemodialysis or haemoperfusion
have been suggested. 3 It is possible that haemoperfusion may
result in a more effective clearance of SV, but at present,
el!lcept for that of Morrensen et al.,4 no reports of its application
are documented. These authors suggested that haemodialysis,
haemoperfusion and glucose infusion contributed towards the
successful treatment of a patient whose blood levels of SV
were 2 120 /-lg/ml. However, other authors3,j suggest that
supportive therapy alone is sufficient in treating these patients.
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A 38-year-old man was admined to the Respiratory Intensive
Care Unit at Tygerberg Hospital after an overdose of sodium
valproate (SV). The time lapse between the ingestion of the
drug and admission and the amount of drug taken were
unknown.
On examination the patient was in coma; the pupils were
dilated and reacted poorly to light. There was general hypotonia
and no abnormal reflexes. He was hypoventilating (3-4 breaths/
min), there was central cyanosis, the left lung was dull on
percussion, and rhonchi and wheezing 'were present. There
was a sinus bradycardia (40/min), and the patient was hypoten-
sive (blood pressure 70/40 mmHg). Blood gas measurements
confirmed the clinical picture of alveolar hypoventilation (partial
arterial pressure of O2 9,9 kPa; partial pressure of CO2 9,9
kPa; pH 7,28; base excess -12; inspired O2 fraction (Fio,)
0,21). The chest radiograph showed patchy consolidation of
the left lung and there were nonspecific ST-T changes on the
ECG.
The patient was intubated and ventilated to correct the
alveolar hypoventilation. Positive end-expiratory pressure was
utilized to minimize the venous shunt and ventilation-perfusion
defects (arterio-alveolar oxygen tension difference 7,1 kPa) and
to allow for an Fio, of less than 0,5. Central venous pressure
was 18 cm H 20 and dopamine 5 /-lg/kg/min was given for the
first 8 hours to improve myocardial contractility. Theophylline
was infused at 4 mg/kg over 30 minutes and continued at 0,7
mg/kg/h. The cardiopulmonary condition improved and, since
the pulmonary physician was not sure whether the patient had
aspirated solid material, a bronchoscopy was performed to clear
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Fig. 2. A semilogarithmic plot of the data from Fig. 1. The straight
line obtained confirms the first-order kinetics of SV notwith-
standing the two periods of haemoperfusion indicated on Fig. 1.
where dCp/dt = change in plasma concentration at time t;
Cp(t) = plasma concentration at time t; and k = proportionality
constant.
If k is solved for the various segments of the curve in Fig. I,
it yields a constant O,OOl/min except for the final pan of the
curve where the value is equal to 0,OOO6/min or, by approxima-
tion, O,OOl/min. This k value implies a 0,1% decay in plasma
concentration per minute. Clearly the amount of drug removed
from the plasma in the initial phases was greater than that
It would appear that on our patient's admission the SV was
still in the distribution phase, since the second value recorded
was higher than the fust (see Fig. I). However, more and
earlier data points would be required to verify this impression.
In general, Fig. I suggests a first-order kinetic process.
First-order kinetics are characterized by a differential equation
that defines a proportionality constant (k).6 This constant
(lmin) relates the rate of change to plasma concentration:
dCp/dt = k Cp(t)
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removed in the fmal phases, but the fraction removed (i.e.
normalized to the absolute level) is constant. Ploning the
available data on a semilogarithmic scale yields a straight line
(Fig. 2). Furthermore, utilizing the basic formula:
ktlog Cp(t) = log Cp(o)---
2,303
a slope of 0,05 (hours v. log) was obtained. This is equal to the
k of 0,001 (min v. log). A regression analysis performed on the
data (h v. log blood concentration) gave y = 0,05x + 6,77 and
r = 0,99. The latter was tested for significance using t =
%-2r --l-r2
and the r value was significant at the 0,1 % level (degrees of
freedom = 5).
In conclusion, we would suggest that haemoperfusion did
not alter the first-order kinetics of SV elimination. If haemo-
perfusion was effective, it would have altered (during the
periods of haemoperfusion at least) the elimination curve as
demonstrated in Fig. I and supportive measures seem to
suffice in the treatment of SV overdose. More data points
would cenainly serve to increase the accuracy of the exponential
curve although, notwithstanding this limitation, we would not
suggest haemoperfusion as an adjuvant in the treatment of an
overdose of SV.
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